Results 201 to 210 of about 205,182 (367)

Combination of fixed low‐dose nivolumab and bendamustine in children with high‐risk relapsed/refractory classical Hodgkin lymphoma

British Journal of Haematology, EarlyView.
A retrospective study of 18 pediatric patients with high‐risk relapsed/refractory classical Hodgkin lymphoma demonstrated that a fixed low‐dose combination of nivolumab and bendamustine achieved an 88% complete response rate, with 1‐year progression‐free survival (PFS) of 88.2% and overall survival (OS) of 94.4%.
Shyam Srinivasan, Aditya Narayan, Chetan Dhamne, Akanksha Chichra, Poonam Khemani, Nidhi Dhariwal, Raghwesh Ranjan, Sneha Shah, Tanuja Shet, Venkata Rama Mohan Gollamudi, Nirmalya Roy Moulik, Shripad D. Banavali, Gaurav Narula   +12 more
wiley   +1 more source

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma [PDF]

, 2001
Luis F. Porrata, Morie A. Gertz, David J. Inwards, Mark R. Litzow, Martha Q. Lacy, Ayalew Tefferi, Dennis A. Gastineau, Angela Dispenzieri, Stephen M. Ansell, Ivana N. Micallef, Susan M. Geyer, Svetomir N. Markovic   +11 more
openalex   +1 more source

Anaplastic large cell lymphoma in children and adolescents

British Journal of Haematology, EarlyView.
Summary Anaplastic lymphoma kinase (ALK)‐positive anaplastic large‐cell lymphoma (ALCL) accounts for >95% of ALCL cases in children and adolescents. The first description of ALCL as a CD30‐positive lymphoma in 1985 was followed by the detection of chromosomal translocations involving the ALK gene at chromosome 2p23.
Eric J. Lowe, Wilhelm Woessmann
wiley   +1 more source

Flexible bronchoscopy in the diagnosis of pulmonary infiltrates following autologous peripheral stem cell transplantation for advanced breast cancer [PDF]

, 2001
AO Soubani, M. Hamza Qureshi, RD Baynes
openalex   +1 more source

Cytomegalovirus reactivation triggers the late onset of hyperthyroidism after autologous peripheral blood transplantation

Leukemia Research Reports, 2019
Thyroid dysfunction is an important issue in patients receiving autologous and allogenic hematopoietic stem cell transplantation (HSCT). However, the exact mechanisms underlying thyrotoxicosis secondary to HSCT remain unclear.
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
doaj  

Autologous stem cell transplantation for acute myeloid leukemia in first remission

, 2000
Charles Linker, Curt A. Ries, Lloyd E. Damon, Peter H. Sayre, Willis H. Navarro, Hope S. Rugo, Arnold D. Rubin, Delvyn C. Case, Pamela Crilley, David Topolsky, Isadore Brodsky, Ken Zamkoff, Jeffrey L. Wolf   +12 more
openalex   +1 more source

Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation [PDF]

, 2001
B.R. Dey, S McAfee, Robert Sackstein, Christine Colby, Susan L. Saidman, Dina Weymouth, Cathleen Poliquin, Julie Vanderklish, David H. Sachs, Megan Sykes, Thomas R. Spitzer   +10 more
openalex   +1 more source

Mesenchymal Stem Cell Therapy for Perianal Crohn's Disease: Surgical Appraisal of Evidence and Translational Potential

ANZ Journal of Surgery, EarlyView.
Rathin Gosavi, Charlotte Keung, Gregory Moore, T. C. Nguyen, William Teoh, Raymond Yap, Paul McMurrick, Vignesh Narasimhan   +7 more
wiley   +1 more source

Screening for monoclonal gammopathy of undetermined significance is contraindicated

British Journal of Haematology, EarlyView.
Incidence of multiple myeloma is about 1.8/100 000. About 3%–5% of adults >50 years of age are diagnosed with monoclonal gammopathy of undetermined significance (MGUS). The prevalence is higher if diagnosis is based on an abnormal ratio of serum free light chains.
Gurmukh Singh
wiley   +1 more source

Is Salvage Autologous Stem Cell Transplantation Still a Viable Treatment Option in Relapsed Myeloma Patients? [PDF]

Medicina (Kaunas)
Čemažar L, Škerget M, Skopec B.
europepmc   +1 more source